helping restore our WAY OF LIFE helping restore our WAY OF LIFE helping restore our WAY OF LIFE

ATTENTION FSD PHARMA SHAREHOLDERS:

For information related to the upcoming Annual & Special Meeting to be held on May 14th, 2021 please click here.

Thank you for your support.

About Us

FSD Pharma, Inc. is a publicly traded holding company, since May 2018.

FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201 ultra-micronized palmitoylethanolamide (PEA). Ultra-Micro PEA stabilizes mast cells and down-regulates the pro-inflammatory cytokines to effectuate an anti-inflammatory response; it is also known to target the CB2 receptors of the endocannabinoid system of the human body.

Our Mission

We are a specialty pharmaceutical research and development company focused on developing FDA approved prescription medications to deliver better treatment outcomes and produce positive and sustainable shareholder value.

News

ATTENTION FSD PHARMA SHAREHOLDERS:


For information related to the upcoming Annual & Special Meeting to be held on May 14th, 2021 please click here.

Thank you for your support.